Colorectal Cancer Therapeutics Market Analysis

Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Embolization, Surgery)

The global colorectal cancer therapeutics market is segmented and analyzed for demand and supply by therapy into targeted therapy, immunotherapy, chemotherapy, radiation therapy, embolization, surgery, and others. Out of these, the targeted therapy segment is projected to significantly grow over the forecast period on the back of its highly effective and lifesaving functions, and increasingly sophisticated therapeutics. For instance, chemotherapy sessions offer only around a 25% chance of success, whereas targeted therapy is close to 75% effective.

Our in-depth analysis of the global market includes the following segments:

By Therapy	Targeted Therapy Immunotherapy Chemotherapy Radiation Therapy Embolization Surgery Others
By Cancer Type	Colorectal Adenocarcinoma Gastrointestinal Carcinoid Tumors Others
By Application	Hospitals Clinics Research Institutions
By End-User	Hospitals Ambulatory Surgical Centers Clinics Diagnostic Imaging Centers Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of colorectal cancer therapeutics is evaluated at USD 24.11 billion.

The colorectal cancer therapeutics market size was over USD 22.36 billion in 2024 and is projected to reach USD 75.39 billion by 2037, witnessing around 9.8% CAGR during the forecast period i.e., between 2025-2037. Worldwide increasing prevalence of cancer, emerging novel therapies for cancer treatment, significant research on novel drugs, and global surge in geriatric population will boost the market growth.

North America industry is predicted to dominate majority revenue share of 31% by 2037, driven by escalating incidences of colorectal cancer coupled with supportive government initiatives along with rising healthcare expenditure, rising number of colon cancer, and increasing awareness among people regarding the screening of colorectal cancer in the region.

The major players in the market include Novartis AG, Pfizer Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Bayer AG, Amgen Inc., Genentech, Inc., Teva Pharmaceuticals Industries Ltd., Ipsen Biopharmaceuticals, Inc.

Colorectal Cancer Therapeutics Market Analysis